ARCHIVES

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

This article is from The Cancer Letter archive.

Vol. 40 No. 06 | February 7, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Approves Mylotarg For First Relapse Of Acute Myeloid Leukemia In Patients 60+.

June 2, 2000

In Brief: Susan Hubbard Names Director Of International Cancer information Center; Includeds ICRDB, PDQ

September 14, 1984

DCC Board Approves Concept for Computer System To Reduce Dependence On NIH

June 1, 1990

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

September 26, 2008

In Brief: NCAB To Protest Tobacco Ads In ‘Family Circle’; ACS Petitions For Taxol Source Designation

October 19, 1990

Funding Opportunity: Defense Department Offering $30.5 Mil In Research Grants

April 18, 2014